Wealth Alliance’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Wealth Alliance's XBI Position: Q1 2026 in Review
Wealth Alliance held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 2,710 shares worth $346K. The position accounts for 0.03% of the portfolio, ranked #391.
Wealth Alliance first reported a position in XBI in Q4 2020 and has held it in 19 quarters since. The position peaked at $452K in Q4 2022. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Wealth Alliance held 2,710 shares of State Street SPDR S&P Biotech ETF worth $346K as of Q1 2026.
- Wealth Alliance left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.03% of Wealth Alliance's portfolio in Q1 2026, its #391 holding.
- Wealth Alliance first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 19 quarters since.
- Wealth Alliance's State Street SPDR S&P Biotech ETF position peaked at $452K in Q4 2022.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.